Background and Objectives: Considering non-invasiveness, sensitivity and appropriateness of Magnetic Resonance Spectroscopy (MRS) and its ability to detect prostate lesions in the early stages; this systematic review aimed to review the MRS efficacy to distinguish benign and malignant prostate lesions. Subjects and Methods: PubMed, Science Direct, Embase, Cochran and Scopus databases were explored using the MRS & prostate, prostate, prostatitis, BPH, and MRS keywords. The obtained results were screened for the title and abstract by two authors and related studies were selected for our systematic review. Results: Sensitivity, specificity and accuracy of MRS were 74. 03, 74. 27 and 77. 26%, respectively in differentiating benign and malignant prostate lesions. The increase of choline and myoinozytol, reduction of citrate and polyamine, and the ratio of the higher sum of choline and creatine to citrate in malignant lesions were presented as the main markers. Conclusion: MRS, as a non-invasive method, has an acceptable level of sensitivity, specificity and accuracy comparable to other clinical and pathological methods.